Related Experiment Video
Updated: Feb 4, 2026

Using Micro-Electro-Mechanical Systems MEMS to Develop Diagnostic Tools
Published on: October 1, 2007
Immunohistochemistry as a diagnostic tool in pathology
Divya Jayagopal1, Kantharaju K H2, Himanshu Shekhar3
1Department of Pathology, ACS Medical College, Velappanchavadi, Chennai, Tamil Nadu, India.
Insights
Immunohistochemistry (IHC) is a vital pathology tool for visualizing antigens in patient tissues using labeled antibodies. Advances in IHC enhance tumor classification, pathogen identification, and targeted therapy administration.
Area of Science:
- Pathology
- Immunology
- Oncology
Background:
- Immunohistochemistry (IHC) visualizes antigens in patient tissue specimens using labeled antibodies.
- It aids in tumor classification, pathogen identification, and prognostic marker discovery, especially when morphological assessment is limited.
Purpose of the Study:
- To highlight the significance of immunohistochemistry in clinical pathology.
- To discuss the evolution and impact of IHC in cancer diagnosis and treatment.
Main Methods:
- Utilizes labeled antibodies directed against specific antigens in tissue samples.
- Employs routine IHC techniques, monoclonal antibodies, and automated stainers for enhanced sensitivity and specificity.
Main Results:
- Routine IHC improves tumor classification, metastasis origin determination, and targeted therapy administration.
- Monoclonal antibodies and automated stainers increase antigen detection sensitivity and specificity.
Conclusions:
- Immunohistochemistry is indispensable for modern clinical pathology, particularly in oncology.
- Ongoing innovations in IHC, including new biomarkers and multiplexing, continue to advance diagnostic capabilities.
Abstract:
Immunohistochemistry (IHC) is an important tool in pathology and allows visualization of antigens when obtaining tissue specimens from patients and employs labeled antibodies directed against those antigens. IHC is helpful to improve tumor classification, identify pathogens and discover prognostic markers when distinguishing features are absent or minimized by morphological assessment. As routine IHC has emerged over the years, monoclonal antibodies and further development of automated stainers allow for increased sensitivity and specificity of antigens assessed by IHC. Since cancer classification relies upon IHC to subtype cancers, define the origin of metastases and to administer targeted therapy, IHC remains a valuable and necessary process for clinical pathology. Innovations continue to be made in IHC, such as new biomarkers, multiplexing and fluorescent technology.
Related Concept Videos
Immunocytochemistry and Immunohistochemistry
These...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pericarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

